Conference
A randomized phase 3 trial of thalidomide and prednisone (TP) as maintenance therapy following autologous stem cell transplantation (ASCT) in patients with multiple myeloma (MM): An updated analysis of the NCIC Clinical Trials Group MY10 trial.
Authors
Hay AE; Trudel S; Bahlis NJ; White D; Sabry W; Belch A; Reiman TJ; Roy J; Shustik C; Kovacs MJ
Volume
32
Pagination
pp. 8591-8591
Publisher
American Society of Clinical Oncology (ASCO)
Publication Date
May 20, 2014
DOI
10.1200/jco.2014.32.15_suppl.8591
Conference proceedings
Journal of Clinical Oncology
Issue
15_suppl
ISSN
0732-183X